Swiss National Bank’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NUVB
OFM
DFO
Swiss National Bank's NUVB Position: Q2 2026 in Review
Swiss National Bank increased its Nuvation Bio (NUVB) stake by 11% in Q2 2026, buying an estimated $241K and bringing the position to 486,800 shares worth $2.77M. The position accounts for ﹤0.01% of the portfolio, ranked #1757.
Swiss National Bank first reported a position in NUVB in Q2 2021 and has held it in 19 quarters since. The position peaked at $3.92M in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.
- Swiss National Bank held 486,800 shares of Nuvation Bio worth $2.77M as of Q2 2026.
- Swiss National Bank bought 49,400 Nuvation Bio shares in Q2 2026, an estimated $241K.
- Nuvation Bio made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1757 holding.
- Swiss National Bank first reported a position in Nuvation Bio in Q2 2021 and has held it in 19 quarters since.
- Swiss National Bank's Nuvation Bio position peaked at $3.92M in Q4 2025.
- 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.
Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.